SCHEMBL7481528

SCHEMBL7481528

CCOC(=O)c1cc(C)n(-c2ccc(OCC)cc2C(=O)O)n1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 1/20 0.45
ALDH1A1 P00352 1/20 0.45
CYP1A2 P05177 1/20 0.45
HPGD P15428 1/20 0.45
TSHR P16473 1/20 0.45
SMN1; SMN2 Q16637 1/20 0.45
HSD17B10 Q99714 1/20 0.45
POLB P06746 2/20 0.45
TDP1 Q9NUW8 2/20 0.45
APEX1 P27695 1/20 0.45
RECQL P46063 1/20 0.45
CTDSP1 Q9GZU7 1/20 0.45
L3MBTL1 Q9Y468 1/20 0.45
TP53 P04637 2/20 0.44
MAPT P10636 3/20 0.44
BCL2 P10415 3/20 0.44
KMT2A Q03164 2/20 0.44
MDM2 Q00987 2/20 0.44
MCL1 Q07820 2/20 0.44
GAA P10253 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7237443 0.91 POLB (0.53) KDM4EALDH1A1HPGDPOLBTDP1
SCHEMBL15057593 0.84 MYC (0.52) ALDH1A1SMN1; SMN2POLBTDP1APEX1
SCHEMBL15057277 0.81 KMT2A (0.52) ALDH1A1SMN1; SMN2L3MBTL1TP53MAPT
SCHEMBL3096202 0.81 CA9 (0.57) TP53MAPTKMT2AGAA
SCHEMBL3299372 0.74 KMT2A (0.68) ALDH1A1POLBTDP1TP53MAPT
SCHEMBL7231829 0.74 TP53 (0.49) KDM4EALDH1A1HPGDHSD17B10POLB
SCHEMBL1877549 0.74 TP53 (0.63) KDM4EALDH1A1SMN1; SMN2HSD17B10POLB
SCHEMBL18017546 0.73 KMT2A (0.57) KDM4EALDH1A1POLBTDP1TP53
SCHEMBL7229599 0.73 POLB (0.62) KDM4EALDH1A1HPGDSMN1; SMN2HSD17B10
SCHEMBL930228 0.73 ALDH1A1 (0.59) KDM4EALDH1A1CYP1A2HPGDTSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-1999032454-A9 NITROGEN CONTAINING HETEROAROMATICS WITH ORTHO-SUBSTITUTED P1'S AS FACTOR XA INHIBITORS DU PONT PHARM CO (US) 2001-05-31 WO disclosed